Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC). - Brueckl,W.M.; Schoeberl,A.; Wirtz,R.M. (J Thorac Oncol, 2008)